Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)

v3.19.1
Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Equity [Abstract]    
Stock Option Outstanding, Beginning Balance 93,203,369
Stock Option Outstanding, Granted 1,350,000 93,203,369
Stock Option Outstanding, Cancelled
Stock Option Outstanding, Exercised
Stock Option Outstanding, Ending Balance 94,553,369 93,203,369
Stock Option Outstanding, Exercisable 93,886,702  
Weighted Average Exercise Price, Beginning Balance $ 0.029
Weighted Average Exercise Price, Granted 0.034 0.029
Weighted Average Exercise Price, Cancelled
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Ending Balance 0.029 $ 0.029
Weighted Average Exercise Price, Exercisable $ 0.029  
Weighted Average Remaining Contractual Term (years), Outstanding Beginning 3 years 11 months 15 days  
Weighted Average Remaining Contractual Term (years), Outstanding Ending 2 years 11 months 8 days 3 years 11 months 15 days
Weighted Average Remaining Contractual Term (years), Exercisable 2 years 11 months 12 days  
Aggregated Intrinsic Value, Outstanding $ 2,721,538
Aggregated Intrinsic Value, Exercisable